WTAP缺失间充质干细胞外泌体通过m6A依赖性表观沉默RPL9减轻OGD/R触发的SK-N-SH细胞损伤
该研究在SK-N-SH细胞氧糖剥夺/复氧(OGD/R)模型中,比较未转染间充质干细胞外泌体(MSCs Exo)与shRNA-WTAP转染间充质干细胞外泌体(MSCs Exo-shWTAP)的作用。结果显示RPL9在缺血性卒中血清和OGD/R暴露的SK-N-SH细胞中上调,敲低RPL9可减轻凋亡、氧化应激(ROS、MDA、SOD)及促炎因子(TNF-α、IL-6、IL-1β)。WTAP通过m6A依赖性方式调控RPL9 mRNA稳定性与表达;MSCs Exo-shWTAP较MSCs Exo对RPL9的下调及对细胞损伤的缓解作用更强,而过表达RPL9可消除MSCs Exo-shWTAP的保护效应。结论提示WTAP缺失的MSC外泌体是缺血性卒中的潜在治疗策略,但仅为细胞水平证据。
要点
- 在OGD/R暴露的SK-N-SH细胞中,MSCs Exo-shWTAP较MSCs Exo对RPL9表达的下调作用更强,对凋亡、氧化应激和炎症的缓解作用也更强。
- RPL9在缺血性卒中血清和OGD/R暴露的SK-N-SH细胞中上调;敲低RPL9可减轻OGD/R诱导的凋亡、氧化应激及TNF-α、IL-6、IL-1β产生。
- WTAP通过m6A依赖性方式调控RPL9 mRNA稳定性与表达。
- 过表达RPL9可消除MSCs Exo-shWTAP对OGD/R诱导细胞损伤的保护效应。
- 上述结果均来自SK-N-SH细胞体外实验,尚未在动物或临床中验证。
适用人群与场景
- 体外培养的SK-N-SH细胞,暴露于氧糖剥夺/复氧(OGD/R)条件。
- 缺血性卒中患者血清用于检测RPL9表达(原文仅提及血清来源,未描述具体人群特征)。
研究设计与关键结果
- 研究类型为体外细胞实验;SK-N-SH细胞暴露于OGD/R,分别用未转染MSCs外泌体(MSCs Exo)或shRNA-WTAP转染MSCs外泌体(MSCs Exo-shWTAP)孵育。
- 检测指标包括细胞活力、凋亡、氧化应激标志物(ROS、MDA、SOD)及TNF-α、IL-6、IL-1β细胞因子产生。
- RPL9在缺血性卒中血清和OGD/R暴露的SK-N-SH细胞中上调;RPL9敲低减轻OGD/R诱发的凋亡、氧化应激和促炎因子产生。
- MSCs Exo降低OGD/R暴露SK-N-SH细胞中RPL9表达,MSCs Exo-shWTAP的降低作用更强;MSCs Exo-shWTAP较MSCs Exo对OGD/R触发的凋亡、氧化应激和炎症的缓解作用更强。
- 过表达RPL9可消除MSCs Exo-shWTAP的上述效应。
证据类型、等级与局限
- 证据类型:体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
- 研究结果为WTAP缺失的MSC外泌体通过下调RPL9减轻OGD/R细胞损伤提供了体外机制证据,作者认为其是缺血性卒中的潜在治疗策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background : Exosomes from mesenchymal stem cells (MSCs Exo) have emerged as a promising cell-free therapeutic strategy for human diseases, including ischemic stroke (IS). Here, we investigated the mechanisms underlying the therapeutic potential of MSCs Exo. Methods : SK-N-SH cells were exposed to oxygen-glucose deprivation/reoxygenation (OGD/R). Exosomes were isolated from untransfected (MSCs Exo) or shRNA-Wilms' tumor 1-associated protein (WTAP)-transfected MSCs (MSCs Exo-shWTAP) and used to incubate OGD/R-exposed SK-N-SH cells. The influence on cellular damage was evaluated by detecting cell viability, apoptosis, the expression of oxidative stress markers (ROS, MDA, and SOD), and the production of TNF-α, IL-6, and IL-1β cytokines. The regulation of WTAP in ribosomal protein L9 (RPL9) mRNA was assessed by mRNA stability analysis and methylated RNA immunoprecipitation (MeRIP) assay. Results : RPL9 was upregulated in IS serum and OGD/R-exposed SK-N-SH cells. RPL9 depletion attenuated OGD/R-evoked apoptosis, oxidative stress, and proinflammatory cytokine production (TNF-α, IL-6, and IL-1β) in SK-N-SH cells. Mechanistically, WTAP regulated the mRNA stability and expression of RPL9 via an m6A-dependent way. MSCs Exo reduced RPL9 expression in OGD/R-exposed SK-N-SH cells, and MSCs Exo-shWTAP exerted a stronger reduction effect on RPL9 expression. MSCs Exo-shWTAP had stronger alleviative effects on OGD/R-triggered apoptosis, oxidative stress, and inflammation in SK-N-SH cells compared with MSCs Exo. Moreover, increased RPL9 expression abolished the effects of MSCs Exo-shWTAP. Conclusion : Our findings indicate that WTAP depletion can enhance the alleviative effects of MSCs Exo on OGD/R-triggered cellular damage in SK-N-SH cells by downregulating RPL9. WTAP-depleted MSC-derived exosomes represent a promising therapeutic strategy for IS.
参考来源
- Wang J, Wang X, Feng L, et al. EXOSOMES FROM WTAP-DEPLETED MESENCHYMAL STEM CELLS MITIGATE OGD/R-TRIGGERED CELLULAR INJURY IN SK-N-SH CELLS THROUGH M6A-DEPENDENT EPIGENETIC SILENCING OF RPL9. Shock. 2025. PMID: 40267514. doi:10.1097/SHK.0000000000002612
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。